BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12854871)

  • 1. Original article pilot screening for fragile X carrier in pregnant women of southern Taiwan.
    Huang KF; Chen WY; Tsai YC; Lin CC; Chen SH; Tseng CY; Tzeng CC
    J Chin Med Assoc; 2003 Apr; 66(4):204-9. PubMed ID: 12854871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot fragile X screening in normal population of Taiwan.
    Tzeng CC; Cho WC; Kuo PL; Chen RM
    Diagn Mol Pathol; 1999 Sep; 8(3):152-6. PubMed ID: 10565687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.
    Toledano-Alhadef H; Basel-Vanagaite L; Magal N; Davidov B; Ehrlich S; Drasinover V; Taub E; Halpern GJ; Ginott N; Shohat M
    Am J Hum Genet; 2001 Aug; 69(2):351-60. PubMed ID: 11443541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of blood spot PCR in large-scale screening of fragile X syndrome in southern Taiwan.
    Chow JC; Chen DJ; Lin CN; Chiu CY; Huang CB; Chiu PC; Lin CH; Lin SJ; Tzeng CC
    J Formos Med Assoc; 2003 Jan; 102(1):12-6. PubMed ID: 12684606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of the FMR1 mutation in Taiwan assessed by large-scale screening of newborn boys and analysis of DXS548-FRAXAC1 haplotype.
    Tzeng CC; Tsai LP; Hwu WL; Lin SJ; Chao MC; Jong YJ; Chu SY; Chao WC; Lu CL
    Am J Med Genet A; 2005 Feb; 133A(1):37-43. PubMed ID: 15637705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.
    Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A
    Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An effective strategy of using molecular testing to screen mentally retarded individuals for fragile X syndrome.
    Tzeng CC; Lin SJ; Chen YJ; Kuo PL; Jong YJ; Tsai LP; Chen RM
    Diagn Mol Pathol; 2001 Mar; 10(1):34-40. PubMed ID: 11277393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 15-year-long Southern blotting analysis of FMR1 to detect female carriers and for prenatal diagnosis of fragile X syndrome in Taiwan.
    Tzeng CC; Tsai LP; Chang YK; Hung YJ; Chang YY; Su YP; Jiang JJ; Liang HM
    Clin Genet; 2017 Aug; 92(2):217-220. PubMed ID: 28139839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FMR1 gene deletion/reversion: a pitfall of fragile X carrier testing.
    Gasteiger M; Grasbon-Frodl E; Neitzel B; Kooy F; Holinski-Feder E
    Genet Test; 2003; 7(4):303-8. PubMed ID: 15000806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A PCR-based test suitable for screening for fragile X syndrome among mentally retarded males.
    Haddad LA; Mingroni-Netto RC; Vianna-Morgante AM; Pena SD
    Hum Genet; 1996 Jun; 97(6):808-12. PubMed ID: 8641701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile X syndrome carrier screening in the prenatal genetic counseling setting.
    Cronister A; DiMaio M; Mahoney MJ; Donnenfeld AE; Hallam S
    Genet Med; 2005 Apr; 7(4):246-50. PubMed ID: 15834242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
    Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
    JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A strategy for fragile-X carrier screening.
    Melis MA; Addis M; Lepiani C; Congeddu E; Cossu P; Cao A
    Genet Test; 1999; 3(3):301-4. PubMed ID: 10495931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.
    Brown WT; Houck GE; Jeziorowska A; Levinson FN; Ding X; Dobkin C; Zhong N; Henderson J; Brooks SS; Jenkins EC
    JAMA; 1993 Oct; 270(13):1569-75. PubMed ID: 8371467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragile X syndrome carrier screening in pregnant women in Chinese Han population.
    Hung CC; Lee CN; Wang YC; Chen CL; Lin TK; Su YN; Lin MW; Kang J; Tai YY; Hsu WW; Lin SY
    Sci Rep; 2019 Oct; 9(1):15456. PubMed ID: 31664061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation of the CGG repeat in FMR-1 gene in normal and fragile X Chinese subjects.
    Chen TA; Lu XF; Che PK; Ho WK
    Ann Clin Biochem; 1997 Sep; 34 ( Pt 5)():517-20. PubMed ID: 9293305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.